Maud Bouvier

Maud BOUVIER currently serves as Associate Vice President of Discovery Business Development at Evotec, beginning in March 2024. Prior to this role, Maud BOUVIER was Vice President of Business Development at Sangamo Therapeutics France from 2018 to April 2024, focusing on out-licensing and in-licensing efforts for the Cell Therapy/CAR-Treg platform in autoimmune diseases. From December 2015 to 2018, Maud BOUVIER held the position of Vice President of Business Development at TxCell, where similar responsibilities were undertaken. Earlier experience includes roles at ERYTECH Pharma, where Maud BOUVIER served as Alliance Manager and Business Development Director from 2005 to 2015, and competitive intelligence strategies were managed. Maud BOUVIER holds a Corporate Finance Certificate from EDHEC Business School, a Master’s Degree in Management of Biotech Companies from Grenoble Graduate School of Business, and a PhD in Cell/Cellular and Molecular Biology from Grenoble University.